Titusville, NJ (June 17, 2011) - Ortho-McNeil-Janssen Pharmaceuticals, Inc. is initiating a voluntary recall of one lot of RISPERDAL® (risperidone) 3mg Tablets, marketed by Janssen Division of ...

The healthcare company’s Ortho-McNeil-Janssen subsidiary said today it will partner with Swedish drug maker Diamyd Medical to help advance a potential treatment for type 1 diabetes. The drug is ...

Ortho-McNeil-Janssen announced a voluntary recall of one lot of Risperdal (risperidone) 3mg tablets and one lot of generic risperidone 2mg tablets (Patriot Pharmaceuticals). This recall was ...

Diversified health care products company Johnson & Johnson is cutting about 900 jobs, mainly from its Ortho-McNeil-Janssen Pharmaceuticals unit. The cuts include a mix of attrition and hiring freezes.

RISPERDAL CONSTA is marketed in the U.S. by Janssen(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. and manufactured by Alkermes, Inc. RISPERDAL CONSTA was initially approved for the ...

In the case involving Topamax, the government says Ortho-McNeil-Janssen Pharmaceuticals Inc. will pay over $75 million for alleged illegal promotion of the drug for a variety of psychiatric uses.

Ortho-McNeil-Janssen Pharmaceuticals (OMJPI) is paying Swedish firm Diamyd Medical $45 million up front for joint rights to develop and commercialize the latter’s Phase III-stage Diamyd ...

12/09/2015 DISTRIBUTED for Conference of January 8, 2016. 12/09/2015 Reply of petitioners Ortho-McNeil-Janssen Pharmaceuticals, Inc., fka Janssen Pharmaceutical, Inc., and/or Janssen, L.P., et al.

In the case involving Topamax, the government says Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals unit will pay more than $75 million. That unit’s subsidiary, Ortho-McNeil ...

Barr has received FDA approval to market a generic version of Ortho-McNeil Janssen’s Razadyne ER (galantamine HBr extended-release capsules) in 8mg, 16mg, and 24mg strengths. Razadyne ER is ...

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has entered into a definitive agreement with Ortho-McNeil-Janssen to settle the patent ...

Janssen Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is based in Titusville, New Jersey, and is the only large pharmaceutical company in the United States dedicated solely to mental health.